Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting

Completed

Conditions studied: Insulin Resistance, Fasting

In brief

This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.

Key facts

Study ID

NCT07216989

Run by

University of Minnesota

People needed

14

Starts

2025-08-05

Expected to finish

2026-03-19

Last updated by the study team

2026-07-14

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ages of 18-65 years old
• Not pregnant
• No comorbid conditions
• BMI of 18.5-29.9.
• Has a smartphone

You may not qualify if…

• Concern for active eating disorder per screening questionnaire
• Self-reported eating disorder or history of eating disorder
• History of hypoglycemia or contraindication for Prolonged Fasting
• Weight <120lbs
• History of blood donation within the last 3 months.

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.